|
|
Alternate Name(s): AAT deficiency ...... Alpha-1 antitrypsin deficiency is a lack of a liver protein that blocks the destructive effects of certain enzymes. The condition may lead to emphysema and liver disease .
|
||
|
The primary NIH organization for research on Alpha-1 Antitrypsin Deficiency is the National Heart, Lung, and Blood Institute ... Guide for the Recently Diagnosed Individual: Alpha-1 Antitrypsin Deficiency(Alpha One Foundation) - Large PDF file...
|
||
|
Alpha 1-antitrypsin deficiency - Wikipedia, the free encyclopedia
|
||
|
Alpha 1-antitrypsin - Wikipedia, the free encyclopedia
|
||
|
The Alpha-1 Association is a member-based not-for-profit organization dedicated to identifying those affected by Alpha-1 Antitrypsin Deficiency (Alpha-1) and to improve the quality of their lives through support, education, advocacy and to encourage participation in research.
|
||
|
Alpha-1 antitrypsin deficiency is an inherited disorder that may cause lung disease and liver disease. ... People with alpha-1 antitrypsin deficiency usually develop the first signs and symptoms of lung disease between ages 20 and 50. The earliest symptoms are shortness of breath following mild activity,
|
||
|
Overview: Alpha1-antitrypsin (AAT) deficiency, first described in 1963, is one of the most common inherited disorders among white persons. Its primary manifestation is early-onset panacinar emphysema. About 1-3% of patients with diagnosed chronic obstructive pulmonary disease (COPD) ... ... alpha1-antitrypsin deficiency,
|
||
|
The Alpha-1 Foundation is dedicated to providing the leadership and resources that will result in increased research, improved health, worldwide detection, and a cure for Alpha-1 Antitrypsin Deficiency. ... What is Alpha-1 Antitrypsin Deficiency? A hereditary condition which may result in serious lung disease in adults and...
|